GlassScriptPhysician profile
Bridgette Bain
NPI 1760647093
$2,172.32
in general payments reported to CMS, 2019-2025
13 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $345 · 2024: $1,252 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $365.18 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $352.85 | 2024-2025 | Austedo Xr, Austedo Xr |
| Alkermes, INC. | $237.71 | 2024-2025 | Lybalvi |
| Abbvie INC. | $231.95 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $120.61 | 2024 | Camzyos |
| Alnylam Pharmaceuticals INC. | $117.77 | 2024 | Amvuttra |
| Melinta Therapeutics, LLC | $113.63 | 2024 | Rezzayo |
| Janssen Pharmaceuticals, INC | $112.50 | 2021 | |
| Livanova USA, INC. | $112.47 | 2022 | |
| Axsome Therapeutics, INC. | $112.13 | 2025 | Auvelity |
| Novo Nordisk INC | $107.08 | 2024 | |
| Mallinckrodt Hospital Products INC. | $102.87 | 2024 | Terlivaz |
| Vanda Pharmaceuticals INC. | $85.57 | 2024 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Bain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.